Plasma amylin concentrations in fasted and fed rats quantified by a monoclonal immunoenzymometric assay

Hormone and Metabolic Research

Volumn 30, Issue 9, 1998, Pages 581-585

  Vine, W ^a   Blase, E ^a   Koda, J ^a   Young, A ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

Amylin; Immunoenzymometric assay; Rats

Indexed keywords

AMYLIN; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; ENZYME IMMUNOASSAY; FEEDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE;

ANIMALIA;

EID: 0031753589     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978937     Document Type: Article

References (16)

1. Alam T, Chen L, Ogawa A, Leffert JD, Unger RH, Luskey KL. Coordinate regulation of amylin and insulin expression in response to hypoglycemia and fasting. Diabetes 1992; 41: 508-14
2. Chang JK, Chou J, Butler P, Wang YN, Bu BH, Chang D, Rizza R. Determination of amylin concentration in rat and human plasma. FASEB J 1990; 4: A1226
3. Chou J, Butler PC, Wang YN, Bu BH, Chang D, Carter B, Rizza R, Chang JK. Cosecretion of amylin and insulin in the rat. Diabetes 1990; 39: 133A (Abstract)
4. Dunning BE, Young DA. Plasma and pancreatic amylin to insulin ratios are markedly elevated in obese SHR/N-cp rats. Diabetes 1991; 40: 216A (Abstract)
5. Gedulin BR, Rink TJ, Young AA. Dose-response for glucagonostatic effect of amylin in rats. Metabolism 1997; 46: 67-70
6. Huang HJS, Young AA, Koda JE, Tulp OL, Johnson MJ, Cooper GJS. Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats. Hypertension 1992; 19: 1101-1109
7. Koopmans SJ, van Mansfeld ADM, Jansz HS, Krans HMJ, Radder JK, Frölich M, deBoer SF, Kreutter DK, Andrews GC, Maassen JA. Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues. Diabetologia 1991; 34: 218-24
8. Percy AJ, Trainor DA, Rittenhouse J, Phelps J, Koda JE. Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma. Clin Chem 1996; 42: 576-85
9. Phelps JL, Blase EK, Koda JE. Development and characterization of monoclonal antibodies specific for amylin. Hybridoma 1996; 15: 379-86
10. Pieber TR, Roitelman J, Lee Y, Luskey KL, Stein DT. Direct plasma radioimmunoassay for rat amylin-(1-37): Concentrations with acquired and genetic obesity. Am J Physiol 1994; 267: E156-E164
11. Pieber TR, Stein DT, Ogawa A, Alam T, Ohneda M, Mccorkle K, Chen L, Mcgarry JD, Unger RH. Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia. Am J Physiol 1993; 265: E446-E453
12. Vine W, Smith P, LaChappell R, Percy A, Young AA. Effect of amylin on renal function in the rat. Program and Abstracts. 10th International Congress of Endocrinology poster (P2-59) 1996; 419
13. Young AA, Gedulin BR. Effects of amylin or amylin antagonist infusions on pancreatic function in fasted and fed rats. Horm Metab Res (in submission) 1997
14. Young AA, Gedulin B, Vine W, Percy A, Rink TJ. Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 1995; 38: 642-8
15. Young AA, Vine W, Carlo P, Smith P, Rink TJ, Rumble J, Cooper ME. Amylin stimulation of renin activity in rats: a possible link between insulin resistance and hypertension. J Hypertension 1994; 12: S152 (Abstract)
16. Young AA, Vine W, Gedulin BR, Pittner R, Janes S, Gaeta LSL, Percy A, Moore CX, Koda JE, Rink TJ, Beaumont K. Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin. Drug Devel Res 1996; 37: 231-48